An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial

Author: the PROTEKT Study Group   Massicotte P.   Julian J.A.   Gent M.   Shields K.   Marzinotto V.   Szechtman B.   Chan A.K.   Andrew M.  

Publisher: Elsevier

ISSN: 0049-3848

Source: Thrombosis Research, Vol.109, Iss.2, 2003-01, pp. : 101-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content